Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Chinese Biotech Firm Ascentage Pharma Secures $150m In Series C Round
Venture Capital

Chinese Biotech Firm Ascentage Pharma Secures $150m In Series C Round

by dealstreetasia.com posted 3months ago 46 views
The company says it intends to use the funds to support its product pipeline and build R&D centres and manufacturing facilities. The post Chinese biotech firm Ascentage Pharma secures $150m in Series C round appeared first on DealStreetAsia.